generation of old , aicines go off patent significant headwind, but it has to happen.se things have to be replaced. focused on iseen building a platform for growth to take us forward for the next 10-15 years. we did the transaction with novartis to build the world leading consumer health care company and vaccine company. i believe we have an innovation portfolio that's going to drive our pharmaceuticals business over the next decade. that is what we are focused on executing. we think it can deliver real value. importantly, it allows us to grow organically, not to commit enormous amounts of capital to buy another business. so, i understand that people focus on the share price, but they shouldn't forget the money that we paid back over the last seven years to shareholders. like pfizer say they are at a competitive disadvantage. if pfizer and allegan go ahead and foreign -- fisa becomes a formal neutral company -- >> we are a u.k. domicile company. we pay our taxes where we make our profits. we pay 20% tax in terms of our global business. first of all, that is pretty comp